These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1782061)

  • 41. Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease.
    Cote RJ; Rosen PP; Hakes TB; Sedira M; Bazinet M; Kinne DW; Old LJ; Osborne MP
    Am J Surg Pathol; 1988 May; 12(5):333-40. PubMed ID: 3364618
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.
    Braun S; Kentenich C; Janni W; Hepp F; de Waal J; Willgeroth F; Sommer H; Pantel K
    J Clin Oncol; 2000 Jan; 18(1):80-6. PubMed ID: 10623696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic indicators of metastatic bone disease in human breast cancer.
    Kamby C; Rasmussen BB; Kristensen B
    Cancer; 1991 Nov; 68(9):2045-50. PubMed ID: 1913553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
    Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland JM; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
    J Clin Oncol; 2003 Sep; 21(18):3469-78. PubMed ID: 12972522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone marrow micrometastases in early breast cancer-30-year outcome.
    Mansi J; Morden J; Bliss JM; Neville M; Coombes RC
    Br J Cancer; 2016 Feb; 114(3):243-7. PubMed ID: 26766739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of occult micrometastases in axillary lymph nodes in "node-negative" breast cancer patients.
    Umekita Y; Ohi Y; Sagara Y; Yoshida H
    Jpn J Cancer Res; 2002 Jun; 93(6):695-8. PubMed ID: 12079518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone marrow and sentinel lymph node biopsy in patients with breast cancer: from staging to ultrastaging?
    Fortunato L; Baldi A; Farina M; Campioni M; Amini M; Piro FR; Costarelli L; Pompili P; Vitelli CE
    J Exp Clin Cancer Res; 2006 Dec; 25(4):487-93. PubMed ID: 17310838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
    Braun S; Cevatli BS; Assemi C; Janni W; Kentenich CR; Schindlbeck C; Rjosk D; Hepp F
    J Clin Oncol; 2001 Mar; 19(5):1468-75. PubMed ID: 11230493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognostic significance of marrow micrometastases in women with early breast cancer.
    Kirk SJ; Cooper GG; Hoper M; Watt PC; Roy AD; Odling-Smee W
    Eur J Surg Oncol; 1990 Dec; 16(6):481-5. PubMed ID: 2253792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group.
    Lancet; 1990 Jun; 335(8705):1565-8. PubMed ID: 1972494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis.
    Molino A; Pelosi G; Turazza M; Sperotto L; Bonetti A; Nortilli R; Fattovich G; Alaimo C; Piubello Q; Pavanel F; Micciolo R; Cetto GL
    Breast Cancer Res Treat; 1997 Jan; 42(1):23-30. PubMed ID: 9116315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients.
    Braun S; Schlimok G; Heumos I; Schaller G; Riethdorf L; Riethmüller G; Pantel K
    Cancer Res; 2001 Mar; 61(5):1890-5. PubMed ID: 11280743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Micrometastases in bone marrow in patients with breast cancer.
    Untch M; Harbeck N; Eiermann W
    Br Med J (Clin Res Ed); 1988 Jan; 296(6617):290. PubMed ID: 3124916
    [No Abstract]   [Full Text] [Related]  

  • 57. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
    Madekivi V; Boström P; Aaltonen R; Vahlberg T; Salminen E
    Anticancer Res; 2017 Jul; 37(7):3757-3762. PubMed ID: 28668871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive value of bone marrow accumulation of Tc-99m tetrofosmin for subsequent development of distant metastases in breast cancer.
    Wakasugi S; Tsukuma H; Inaji H; Hashizume T; Noguchi A; Ohnishi T
    Ann Nucl Med; 2007 Oct; 21(8):429-37. PubMed ID: 17952551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DTCs in breast cancer: clinical research and practice.
    Janni W; Rack B; Kasprowicz N; Scholz C; Hepp P
    Recent Results Cancer Res; 2012; 195():173-8. PubMed ID: 22527504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen.
    Dearnaley DP; Sloane JP; Ormerod MG; Steele K; Coombes RC; Clink HM; Powles TJ; Ford HT; Gazet JC; Neville AM
    Br J Cancer; 1981 Jul; 44(1):85-90. PubMed ID: 7020739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.